AOPEP and hyperlipoproteinemia type 3: A small proportion of apo ε2 homozygotes, develop type III hyperlipoproteinemia, a highly atherogenic form disorder of lipoprotein metabolism characterized by the accumulation of remnant particles derived from the incomplete catabolism of triglyceride-rich lipoproteins (März et al., 2000).